Inogen Inc (INGN)

95.52
NASDAQ : Health Care
Prev Close 95.52
Day Low/High 0.00 / 0.00
52 Wk Low/High 44.26 / 97.71
Avg Volume 186.40K
Exchange NASDAQ
Shares Outstanding 20.58M
Market Cap 1.94B
EPS 1.00
P/E Ratio 84.04
Div & Yield N.A. (N.A)

Latest News

Inogen Announces Participation In 37th Annual William Blair Growth Stock Conference

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's management will be participating in the 37th...

INGN Crosses Above Average Analyst Target

In recent trading, shares of Inogen, Inc have crossed above the average analyst 12-month target price of $84.83, changing hands for $85.27/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Inogen Announces First Quarter 2017 Financial Results

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month period ended March 31, 2017.

Inogen To Announce First Quarter 2017 Results On Tuesday, May 9, 2017

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release its financial results for the first quarter of 2017...

Inogen Announces Participation In 16th Annual Needham Healthcare Conference

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's management will be participating in the 16th...

Inogen Reaches Analyst Target Price

In recent trading, shares of Inogen, Inc have crossed above the average analyst 12-month target price of $76.20, changing hands for $76.44/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ALEX, AZN, BDL, INGN, ITRI, PAH Downgrades: AGYS, ASFI, IKNX, PRFT, SIX, VNCE Initiations: SRG Read on to get TheStreet Quant Ratings' detailed report:

Inogen Announces Fourth Quarter And Full Year 2016 Financial Results And Updates 2017 Guidance

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month and twelve-month periods ended...

Inogen Reaches Analyst Target Price

In recent trading, shares of Inogen, Inc have crossed above the average analyst 12-month target price of $69.00, changing hands for $69.21/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Inogen To Announce Fourth Quarter And Full Year 2016 Results On Tuesday, February 28, 2017

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release its financial results for the fourth quarter and full...

Inogen To Participate In Upcoming Investor Conferences

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's management will be participating in two upcoming...

Inogen Provides Impact From 21st Century Cures Act

Inogen Provides Impact From 21st Century Cures Act

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the estimated impact of the 21 st Century Cures Act to its 2016...

Inogen To Participate In Upcoming Investor Conferences

Inogen To Participate In Upcoming Investor Conferences

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that it will be participating in two upcoming investor conferences.

Inogen Announces Management Transitions And Expanded Board Of Directors

Inogen Announces Management Transitions And Expanded Board Of Directors

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that its Board of Directors has appointed Scott Wilkinson as...

Short Interest In Inogen Declines 14.7%

Short Interest In Inogen Declines 14.7%

The most recent short interest data has been released for the 11/15/2016 settlement date, which shows a 305,801 share decrease in total short interest for Inogen, Inc , to 1,771,046, a decrease of 14.72% since 10/31/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Inogen Recognized As One Of The Fastest Growing Companies In North America According To Deloitte's 2016 Technology Fast 500™

Inogen Recognized As One Of The Fastest Growing Companies In North America According To Deloitte's 2016 Technology Fast 500™

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced it was included on Deloitte's Technology Fast 500™, a ranking...

Inogen To Participate In Upcoming Investor Conferences

Inogen To Participate In Upcoming Investor Conferences

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that it will be participating in two upcoming investor conferences.

Inogen Announces Third Quarter 2016 Financial Results

Inogen Announces Third Quarter 2016 Financial Results

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month period ended September 30,...

Inogen To Participate In Upcoming Investor Conferences

Inogen To Participate In Upcoming Investor Conferences

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that it will be participating in two upcoming investor conferences.

Inogen To Announce Third Quarter 2016 Results On Thursday, November 3, 2016

Inogen To Announce Third Quarter 2016 Results On Thursday, November 3, 2016

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release its financial results for the third quarter of 2016...

Inogen Broadens Market Access And Patient Travel Options

Inogen Broadens Market Access And Patient Travel Options

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that its innovative Inogen One G4 portable oxygen concentrator is...

INGN Crosses Above Average Analyst Target

INGN Crosses Above Average Analyst Target

In recent trading, shares of Inogen, Inc have crossed above the average analyst 12-month target price of $54.75, changing hands for $54.78/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Inogen Announces Second Quarter 2016 Financial Results

Inogen Announces Second Quarter 2016 Financial Results

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month period ended June 30, 2016.

Inogen To Announce Second Quarter 2016 Results On Thursday, August 4, 2016

Inogen To Announce Second Quarter 2016 Results On Thursday, August 4, 2016

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release its financial results for the second quarter of 2016...

Inogen (INGN) Showing Signs Of Being Strong And Under The Radar

Inogen (INGN) Showing Signs Of Being Strong And Under The Radar

Trade-Ideas LLC identified Inogen (INGN) as a strong and under the radar candidate

Inogen Announces Participation In 36th Annual William Blair Growth Stock Conference

Inogen Announces Participation In 36th Annual William Blair Growth Stock Conference

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that the Company will be participating in the 36 th Annual William...

Inogen Releases Innovative Inogen One G4™ Oxygen Concentrator

Inogen Releases Innovative Inogen One G4™ Oxygen Concentrator

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the release to market of its innovative Inogen One G4 portable...

Inogen Announces Investor/Analyst Day And Webcast

Inogen Announces Investor/Analyst Day And Webcast

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced it will host an institutional investor and analyst meeting on...